Skip to main content




Phone (Primary):


Download CV

Education and Training

University of Dar es salaam,Tanzania, MD, Medicine, 2002.

Duke University, Durham, MSH, Clinical Research, 2008.

University of North Carolina, Chapel Hill, MPH, Public Health Leadership,  2009.

University of North Carolina, Chapel Hill, PhD, Infectious Disease Epidemiology, 2014.



Habib Omari is an infectious disease medical epidemiologist with 13-year track record of outstanding infectious disease research involving HIV and infections resulting from severe immunodeficiency (i.e. opportunistic infections). His research focuses on improving health of HIV infected patients by exploring and intervening on factors associated with HIV testing, antiretroviral therapy (ART) adherence, treatment failure, resistance mutations and ART switching. Along with infectious disease research, Dr Omari worked as clinician at a consultant referral hospital in Tanzania where he was responsible for management of HIV infected patients.

As an international physician-scientist, he has demonstrated a strong research record and publishing. He served as the principle investigator for the two studies, one CFAR funded and the other AITRP. He is also intergral to a UMB NIH R01 study as a co-investigator entittled, "Building TRUST". Currently as a facult Research Associate with the Institute of Human Virology (IHV), University of Maryland School of Medicine, Dr Omari is working on multiple projects involving HIV/STI treatment and prevention on a cohort of key population individuals involving men who have sex with men (MSM) as well as prevention of mother to child transmission of HIV (PMTCT).



Research/Clinical Keywords

ART adherence, treatment failure, resistance mutations, ART treatment switch, PMTCT, Early infant diagnosis, retention in care, linkage to care, key population, STI,HIV, social network, sexual network, Pre exposure prophylaxis, treatment as prevention, transmission clusters.

Highlighted Publications

Mahande MJ, Phimemon RN, Ramadhani HO. Factors associated with changes in uptake of HIV testing among young women (aged 15-24) in Tanzania from 2003 to 2012. Infect Dis Poverty. 2016;5(1):92. PMID 27595846.

Ramadhani HO, Bartlett JA, Thielman NM, et al. The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania. Open forum infectious diseases. 2016;3(1):ofw018. PMID 26949717

Ramadhani HO, Muiruri C, Maro VP, et al. Association of knowledge on ART line of treatment, scarcity of treatment options and adherence. BMC Health Serv Res. 2016;16(1):265. PMID 27416836.

Ramadhani HO, Liu H, Nowak RG, et al. Sexual partner characteristics and incident rectal Neisseria gonorrhoeae and Chlamydia trachomatis infections among gay men and other men who have sex with men (MSM): a prospective cohort in Abuja and Lagos, Nigeria. Sex Transm Infect. 2017. PMID 28235839.

Nadia A. Sam-Agudu,  Ramadhani HO,  Christopher Isah, Salome Erekaha, Chinenye Fan-Osuala,  Udochisom Anaba; Ebunoluwa A. Adejuyigbe, Manhattan Charurat. The Impact of Structured Mentor Mother Programs on Retention and Viral Suppression at 6 months Postpartum among HIV-Positive Women Visiting Primary Healthcare Centers in Nigeria: A Prospective Paired Cohort Study. JAIDS. J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S173-S181. PMID 28498187. 



Edit Icon - Click to update your profileUpdate Your Profile